9 min
052 - The Next Biotech Gold Rush & How Thermo Fisher Scientific Benefits Yield on Cost Podcast
-
- Näringsliv
Cheap DNA sequencing, increased computing power, powerful new gene editing tools, and AI are setting up the third wave of the biotechnology revolution. And it's coming for industrial production. Mckinsey estimates there are around 400 identifiable and scientifically feasible production processes that could be disrupted by biotechnology. This is around $2-4 trillion of economic activity. Thermo Fisher is the biotech picks and shovels company that will benefit from this new wave of innovation.
Full Write-up
https://mailchi.mp/amminvest/the-next-biotech-goldrush-thermo-fisher-scientific
Subscribe to the Yield on Cost Newsletter
https://mailchi.mp/amminvest/podcast-yoc
Cheap DNA sequencing, increased computing power, powerful new gene editing tools, and AI are setting up the third wave of the biotechnology revolution. And it's coming for industrial production. Mckinsey estimates there are around 400 identifiable and scientifically feasible production processes that could be disrupted by biotechnology. This is around $2-4 trillion of economic activity. Thermo Fisher is the biotech picks and shovels company that will benefit from this new wave of innovation.
Full Write-up
https://mailchi.mp/amminvest/the-next-biotech-goldrush-thermo-fisher-scientific
Subscribe to the Yield on Cost Newsletter
https://mailchi.mp/amminvest/podcast-yoc
9 min